Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apex Healthcare Bhd (XKLS:7090) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Apex Healthcare Bhd's Enterprise Value for the quarter that ended in Sep. 2025 was RM1,573.0 Mil.
Apex Healthcare Bhd's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM93.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd EV-to-EBIT Related Terms
Apex Healthcare Bhd EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Apex Healthcare Bhd's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Apex Healthcare Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's EV-to-EBIT falls into.
Apex Healthcare Bhd's current Enterprise Value is RM1,727.7 Mil.
Apex Healthcare Bhd's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM93.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd (XKLS:7090) has a EV-to-EBIT of 18.55 as of Aug. 14, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Apex Healthcare Bhd and its competitors. This is 35% above median its historical median of 13.77. Over the past decade, Apex Healthcare Bhd's EV-to-EBIT has ranged from 3.04 to 23.17.
Is Apex Healthcare Bhd's EV-to-EBIT too high?
Apex Healthcare Bhd's current EV-to-EBIT of 18.55 is 35% above median its 10-year median of 13.77. Over the past 10 years, this metric has ranged from a low of 3.04 to a high of 23.17. The Medical Distribution industry median EV-to-EBIT is 11.90. Apex Healthcare Bhd's value of 18.55 is 55.9% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's EV-to-EBIT compare to MCK and COR?
Apex Healthcare Bhd's EV-to-EBIT of 18.55 can be compared against companies in the Medical Distribution industry. The industry median EV-to-EBIT is 11.90. Apex Healthcare Bhd's value of 18.55 is 55.9% above this benchmark. Historically, Apex Healthcare Bhd's own EV-to-EBIT has ranged from 3.04 to 23.17 over the past decade. While the company's 10-year median is 13.77 vs. the industry median of 11.90, Apex Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.90, based on 96 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current EV-to-EBIT of 18.55 is 55.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current EV-to-EBIT is 18.55, which is 35% above median its own 10-year median of 13.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current EV-to-EBIT of 18.55. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current EV-to-EBIT is 18.55, which is 35% above median its 10-year median of 13.77 and 55.9% above the Medical Distribution industry median of 11.90. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current EV-to-EBIT is 18.55 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
EV-to-EBIT: 18.55 (35% above median its 10-year median of 13.77)
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
Industry Position: 55.9% above the Medical Distribution median
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
